Number of Shares
45,000.00
Current Holdings Value*
$2.17 Mil
% of Portfolio
3.36%
Total Estimate Gain
$2.71 Mil
% of Total Estimate Gain
88.65%

Fairpointe Capital LLC's NeoGenomics Inc Holding Summary

As of 2021-03-31, Fairpointe Capital LLC held 45,000.00 shares of NeoGenomics Inc(NEO), totaling $2.17 Mil. This investment constitutes 3.36% of their stock portfolio, and Fairpointe Capital LLC now holds 0.04% of the outstanding NeoGenomics Inc(NEO) stock.

The initial trade took place in 2018Q2. In addition, there have been 6 sales at an average price of $23.50 for 233,132.00 shares. Based on historical transaction data and NEO's current price of $6.61, Fairpointe Capital LLC's estimated gain on his NEO holdings is $2.71 Mil, reflecting a 88.65% gain to date.

Fairpointe Capital LLC NEO ($6.61) Holding Chart

Fairpointe Capital LLC NEO ($6.61) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1